J&J Kicks Off $5B Clinical Diagnostics Unit Sale

Johnson & Johnson has launched a sale process for its Ortho Clinical Diagnostics unit, which makes blood screening equipment and laboratoryblood tests and could fetch around $5 billion, three people familiar with the matter said earlier this month, according to sister news service Reuters.